Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Nylander-Lundqvist

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Lakartidningen|December 20, 1995
[ Unlimited cooperation]E Nylander Lundqvist, I Sjöberg
Acta Dermato-Venereologica|May 1, 1997
Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitroE Nylander-Lundqvist, T Egelrud
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
IL-1 beta activation in human epidermisE Nylander-Lundqvist, O Bäck, T Egelrud
Clinical Rheumatology|June 1, 1992
Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseasesE Nylander Lundqvist, O Back, T K Nilsson, et al.
The Biochemical Journal|October 15, 1992
Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligandX F Cheng, O Bäck, T K Nilsson, et al.
The British Journal of Dermatology|July 27, 1999
PUVA and cancer risk: the Swedish follow-up studyB Lindelöf, B Sigurgeirsson, E Tegner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Lakartidningen|December 20, 1995
[ Unlimited cooperation]E Nylander Lundqvist, I Sjöberg
Acta Dermato-Venereologica|May 1, 1997
Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitroE Nylander-Lundqvist, T Egelrud
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
IL-1 beta activation in human epidermisE Nylander-Lundqvist, O Bäck, T Egelrud
Clinical Rheumatology|June 1, 1992
Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseasesE Nylander Lundqvist, O Back, T K Nilsson, et al.
The Biochemical Journal|October 15, 1992
Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligandX F Cheng, O Bäck, T K Nilsson, et al.
The British Journal of Dermatology|July 27, 1999
PUVA and cancer risk: the Swedish follow-up studyB Lindelöf, B Sigurgeirsson, E Tegner, et al.
Pageof 1